Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression
Open Access
- 1 December 2004
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (3), 358-364
- https://doi.org/10.1016/j.jhep.2004.11.020
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evidence‐based medicine in the treatment of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysisGut, 2001
- Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol InjectionRadiology, 1999
- Glucose Catabolism in Cancer CellsJournal of Biological Chemistry, 1997
- Glucose catabolism in cancer cells: regulation of the type II hexokinase promoter by glucose and cyclic AMPFEBS Letters, 1996
- Glucose Catabolism in Cancer Cells.Journal of Biological Chemistry, 1995
- Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver DiseaseNew England Journal of Medicine, 1993
- Independent risk factors for hepatocellular carcinoma in french drinkersHepatology, 1991
- High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinaseProceedings of the National Academy of Sciences of the United States of America, 1977